These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6141825)

  • 41. [The nootropic and anxiolytic properties of different doses of piracetam].
    Voronina TA; Molodavkin GM; Borlikova GG; Ostrovskaia RU; Tushmalova NA; Naznamov GG
    Eksp Klin Farmakol; 2000; 63(2):9-11. PubMed ID: 10834086
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The antiamnestic effect of nootropic substances in rats].
    Iasnetsov VV; Krylova IN
    Eksp Klin Farmakol; 2013; 76(11):3-6. PubMed ID: 24555225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
    dos Reis LM; Canto-de-Souza A
    Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Kubacka M; Mogilski S; Wasik A; Kołaczkowski M; Wesołowska A
    Neuropharmacology; 2014 Oct; 85():253-62. PubMed ID: 24905144
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Reproduction of "passive" avoidance in rats by administering pharmacologic agents].
    Shabanov PD
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1981; 31(1):158-63. PubMed ID: 6113722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two animal models of anxiety--different sensitivity for anxiolytic action of GABAA receptor complex ligands.
    Nazar M; Płaznik A; Jessa M
    Acta Physiol Hung; 1996; 84(4):437-9. PubMed ID: 9328625
    [No Abstract]   [Full Text] [Related]  

  • 47. Novel 3-iodo-8-ethoxypyrazolo[5,1-c][1,2,4]benzotriazine 5-oxide as promising lead for design of alpha5-inverse agonist useful tools for therapy of mnemonic damage.
    Guerrini G; Ciciani G; Cambi G; Bruni F; Selleri S; Besnard F; Montali M; Martini C; Ghelardini C; Galeotti N; Costanzo A
    Bioorg Med Chem; 2007 Apr; 15(7):2573-86. PubMed ID: 17306981
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The search for new anticonvulsant agents based on nicotinamide].
    Akhundov RA; Dzhafarova SA; Aliev AN
    Eksp Klin Farmakol; 1992; 55(1):27-9. PubMed ID: 1305428
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The neurochemical profile of the caudate nucleus in the anxiolytic action of benzodiazepine and nonbenzodiazepine tranquilizers on different models of anxiety].
    Talalaenko AN; Gordienko DV; Markova OP
    Eksp Klin Farmakol; 2000; 63(1):14-8. PubMed ID: 10763103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. N,N'-dicyclohexylsulfamide and N,N'-diphenethylsulfamide are anticonvulsant sulfamides with affinity for the benzodiazepine binding site of the GABA(A) receptor and anxiolytic activity in mice.
    Wasowski C; Gavernet L; Barrios IA; Villalba ML; Pastore V; Samaja G; Enrique A; Bruno-Blanch LE; Marder M
    Biochem Pharmacol; 2012 Jan; 83(2):253-9. PubMed ID: 22056620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GABA-benzodiazepine receptor complex and drug actions.
    Saano V
    Med Biol; 1987; 65(2-3):167-73. PubMed ID: 2888932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of H-Phe-Ile-Tyr-His-Ser-Tyr-Lys-OH on different behavioral tests of rats.
    Vécsei L; Bollók I; Telegdy G; Schally AV
    Exp Brain Res; 1985; 57(3):625-7. PubMed ID: 4038945
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of 3-hydroxypyridine derivatives on the central nervous system].
    Val'dman AV; Voronina TA; Smirnov LD; Tilekeeva UM; Diumaev KM
    Biull Eksp Biol Med; 1985 Jan; 99(1):60-2. PubMed ID: 4038464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [STUDIES OF THE ANTIHYPOXIC AND ANTIAMNESTIC EFFECTS OF MELATONIN IN ANIMALS].
    Yasnetsov VV; Motin VG; Yasnetsov VV; Karsanova SK; Ivanov YV; Chelnaya NA
    Aviakosm Ekolog Med; 2015; 49(5):43-8. PubMed ID: 26738307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Search for α3β₂/₃γ2 subtype selective ligands that are stable on human liver microsomes.
    Namjoshi OA; Wang ZJ; Rallapalli SK; Johnson EM; Johnson YT; Ng H; Ramerstorfer J; Varagic Z; Sieghart W; Majumder S; Roth BL; Rowlett JK; Cook JM
    Bioorg Med Chem; 2013 Jan; 21(1):93-101. PubMed ID: 23218469
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Purinergic control of anxiety: direct behavioral evidence in the rat.
    Wagner JA; Katz RJ
    Neurosci Lett; 1983 Dec; 43(2-3):333-7. PubMed ID: 6324049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies on cognitive enhancing agents. II. Antiamnestic and antihypoxic activities of 1-aryl-2-(2-aminoethoxy)ethanols.
    Ono S; Yamafuji T; Chaki H; Morita H; Todo Y; Maekawa M; Kitamura K; Tai M; Narita H
    Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1488-91. PubMed ID: 7586071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies on cognitive enhancing agents. III. Antiamnestic and antihypoxic activities of a series of 1-bicycloaryl-2-(omega-aminoalkoxy)ethanols.
    Ono S; Yamafuji T; Chaki H; Morita H; Todo Y; Okada N; Maekawa M; Kitamura K; Tai M; Narita H
    Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1492-6. PubMed ID: 7586072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Memory disorders due to extreme impacts and their pharmacological correction].
    Iasnetsov VV
    Aviakosm Ekolog Med; 1996; 30(4):4-14. PubMed ID: 8991574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies on cognitive enhancing agents. I. Antiamnestic and antihypoxic activities of 2-dimethylaminoethyl ethers and related compounds.
    Ono S; Yamafuji T; Chaki H; Todo Y; Maekawa M; Kitamura K; Tai M; Narita H
    Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1483-7. PubMed ID: 7586070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.